UNAIDS Executive Director Winnie Byanyima said HIV infections have been falling in recent years, with just 1.3 million new ...

The funding freeze comes at a critical moment, just as a groundbreaking HIV prevention shot -- lenacapavir (Sunlenca) -- ...

Lenacapavir, already approved for HIV treatment, showed promising results for HIV prevention in two earlier Gilead trials. Wilkins is part of a trial in Atlanta including about 250 cisgender women ...

In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in preventing HIV infections. The findings, published in the New England Journal ...

"This is a moment in time we cannot miss," Meg Doherty from WHO writes to sciencenorway.no. The preventive HIV injectable drug lenacapavir, which was named breakthrough of the year in 2024, could be ...

President Trump's foreign aid freeze, including a 90-day halt on PEPFAR, has disrupted HIV treatment for millions in Africa, risking thousands of newborn infections. Clinics are shutting down ...

Get Instant Summarized Text (Gist) A new, affordable laparoscope called the KeyScope has been developed to make laparoscopic surgery accessible in low- and middle-income countries (LMICs). Priced ...

Companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--#DataSecurity--DNAnexus, the ...

While PrEP pills have been an important tool in HIV prevention, we now have something potentially far more transformative: lenacapavir, recently named Science Magazine’s 2024 “Drug of the Year.” ...

Gilead Sciences achieved a 14% increase in market capitalisation due to the recently submitted a new drug application to the FDA for lenacapavir, a twice-yearly injectable HIV-1 caspid inhibitor for ...

Gilead Sciences, a Californian-based maker, has started trials with a new HIV prevention drug called lenacapavir, which, in its early stages, indicates 100% so far. The latest trial, PURPOSE One, is a ...